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Radiographs and low field MRI (0.2T) as
predictors of efficacy in a weight loss trial in
obese women with knee osteoarthritis
Henrik Gudbergsen1†, Mikael Boesen2†, Robin Christensen1†, Arne Astrup3†, Henning Bliddal1*
Abstract
Background: To study the predictive value of baseline radiographs and low-field (0.2T) MRI scans for the
symptomatic outcome of clinically significant weight loss in obese patients with knee osteoarthritis.
Methods: In this study we hypothesize that imaging variables assessed with radiographs and MRI scans pre-
treatment can predict the symptomatic changes following a recommended clinically significant weight reduction
Patients were recruited from the Department of Rheumatology, Frederiksberg Hospital, Denmark. Eligibility criteria
were: age >18 years; primary osteoarthritis according to ACR; BMI > 28 kg/m2; motivation for weight loss. Subjects
were randomly assigned to either intervention by low-energy diet (LED) for 8 weeks followed by another 24 weeks
of dietary instruction or control-group. MRI scans and radiographs were scored for structural changes and these
parameters were examined as independent predictors of changes in osteoarthritis symptoms after 32 weeks. The
outcome assessor and statistician were blinded to group allocation.
Results: No significant correlations were found between imaging variables and changes in Western Ontario and
McMaster Universities Index of Osteoarthritis (Spearman’s test, r < 0.33 and P > 0.07).
Only the LED group achieved a weight loss, with a mean difference of 16.3 kg (95%CI: 13.4-19.2;P < 0.0001)
compared to the control group. The total WOMAC index showed a significant difference favouring LED, with a
group mean difference of - 321.3 mm (95%CI: -577.5 to -65.1 mm; P = 0.01). No significant adverse events were
reported.
Conclusion: Stage of joint destruction, assessed on either radiographs or low-field MRI (0.2T), does not preclude a
symptoms relief following a clinically relevant weight loss in elderly obese female patients with knee osteoarthritis.
Background
Knee osteoarthritis (KOA) is a multi factorial disease
characterized by joint-stiffness, pain and loss of function
[1]. With an increasing prevalence of elderly and obese
citizens, the problems of KOA is likely to escalate in the
future [2-4], and as new potential treatments arise, there
is a need to examine MRI evaluated structural changes
in clinical trials.
A drug/treatment that can efficiently halt the degenera-
tive nature of KOA (DMOAD) has not yet been pre-
sented, but in obese KOA patients recent studies have
shown a direct relationship between weight loss and the
level of symptomatic improvement [5]. This result sup-
ports earlier epidemiological findings that weight loss
reduces the risk of development and progression of
KOA, and that KOA related symptoms tend to worsen in
obese patients [6-9]. As a consequence, overweight KOA
patients are now recommended to commence weight
reduction as a first line therapy [3,4]. Which diet to
choose is still debated as there is no evidence to support
one diet composition over others; the single most impor-
tant factor is to establish a continuous energy deficit [10].
Conventional radiography is the simplest and least
expensive imaging method for assessing KOA, and the K/L
score remains the most widely applied system when diag-
nosing KOA [11,12] in clinical trials. Both low- and high
field MRI provides additional information to radiographs,
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as these modalities have a unique ability to image all knee
joint related structures [13].
The MRI modality withholds a possibility for semi-
quantitative scoring of synovial thickening, joint effu-
sion, bone marrow lesions (BMLs) and cartilage
abnormalities. These structures are essential because the
synovium, joint capsule and subchondral bone are highly
innervated and appear to represent some of the main
origins of KOA-related pain, whereas the cartilage status
is suggested to be more a marker of joint strain and
thereby a surrogate marker for KOA symptoms [14]. All
of these structural changes have been shown to correlate
with clinical symptoms and/or progression of disease
[15-20], and they therefore seem relevant to examine in
this intervention study.
In this study we hypothesize that imaging variables
assessed with radiographs and MRI scans pre-treatment
can predict the symptomatic changes following a recom-
mended clinically significant weight reduction [5].
Methods
Participants
Following approval from the local ethical committee
((KF) 01-104/02 and 11-149/03), female patients were
recruited from the outpatients’ clinic, Department of
Rheumatology, Frederiksberg Hospital, Denmark. They
were all invited from the waiting list of the first diet
study from the Parker Institute (Christensen, 2005 86/
id). All patients signed and approved the informed con-
sent and standing knee radiographs, MRI and clinical
examinations were performed on the same day at base-
line. The study was carried out in accordance with the
Helsinki Declaration II and the European Guidelines for
Good Clinical Practise.
Eligibility criteria were: age above eighteen years; pri-
mary KOA diagnosed according to the clinical classifica-
tion of KOA [21]; no history or active presence of other
rheumatic diseases that might be responsible for second-
ary KOA; no substantial abnormalities in haematologi-
cal, hepatic, renal, cardiac or endocrine functions
(including diabetes mellitus); body-mass index (BMI)
≥28 kg/m2, expression of a clear, unequivocal motivation
for weight loss; fluent in Danish language.
Only pain medication was monitored in our project:
All participants were asked not to change the previous
medications for pain, i.e. maintain the same medication
at same dosage. The GP was informed of the project
and asked to monitor other medications, including
antidiabetics.
Imaging acquisition
Baseline MRI was obtained of a single knee, using a dedi-
cated extremity scanner (E-Saote E-scanner, 0.2 Tesla,
Software release 9.6B). In case of bilateral symptoms we
examined the most symptomatic one All MRI scans were
performed in the same department of radiology by a
team of two radiographers applying a standardized tech-
nique. Knees were placed in a receive-only cylinder coil.
The imaging protocol used was:
A gradient echo scout followed by a saggital STIR
with 4 mm slices (TR 1460, TE 24, FOV 160 × 160,
matrix 256 × 256, acquisition time 5 min 10 s). Two
successive T1-weighted 3 D gradient-echo sequences
were acquired in the axial and saggital plane with
respectively 104 and 52 adjoining 1.4 mm thick slices
(TR 60 ms, TE 24 ms, 45° flip angle, field of view 150
mm, matrix 192 × 160 and voxel size 0.78 × 1.07 × 1.4
mm 3, acquisition time 6 min). Coronal T1-weighted
spin-echo with 15 contiguous 4 mm thick slices (TR
520 ms, TE 15 ms, field of view 160 mm, matrix 192 ×
160 mm, acquisition time 3 min 20 s with two signals
acquired). Finally a saggital T2*-weighted two-dimen-
sional gradient-echo sequence was acquired with 25
contiguous 4 mm thick sections (TR 60 ms, TE 24 ms,
45° flip angle, field of view 160 mm, matrix 192 × 160,
acquisition time 4 min 50 s).
Bi-plane weight-bearing semi-flexed radiographs were
taken of the index knee; one in the posteroanterior and
one in the lateral view (in case of bilateral symptoms we
used the most symptomatic knee). They were obtained
at inclusion/baseline, using a Philips Optimus apparatus,
and the same radiographers using a standardized proto-
col carried out all examinations. The ionizing radiation
dose per examination was 0.006 mSv corresponding to
0.2% of the annual background radiation on earth (aver-
age background dose for humans are 2.4 mSv annually.
Imaging evaluation
MRI scans were scored separately for four structural
parameters and summed as a “Total MRI Score” to see
if this construct would perform better as an imaging
biomarker. Cartilage abnormalities, BMLs and synovitis
were scored for the medial, lateral and patellofemoral
chamber and effusion was graded according to the total
amount.
Cartilage abnormalities were assessed using the T2*
and the 3 D T1 weighted Gradient echo sequences.
These abnormalities were graded 0-4 according to the
description by Ding et al. [22], and the specific grades
were as follows; grade 0, normal cartilage; grade 1, focal
blistering and an intra-cartilaginous area of low signal
intensity with an intact surface; grade 2, irregularities on
the surface or bottom and a < 50% loss of thickness;
grade 3, deep ulceration, with a > 50% loss of thickness;
grade 4, full-thickness chondral wear, with exposure of
the subchondral bone. BMLs were defined as poorly
marginated areas of increased signal intensity in the
subchondral bone on the STIR images, and they were
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scored according to the description by Torres et al. [23].
The grades were defined as follows; grade 0, normal;
grade 1, < 25% of the chamber, grade 2, 25-50% of the
chamber and grade 3, > 50% of the chamber. The
degree of synovitis was scored according to Rhodes et
al. on a scale ranging from 0-3 where 0 = normal, 1 =
diffuse, even thickening, 2 = nodular thickening and 3 =
gross nodular thickening [24]. The amount of effusion
was graded from 0-3 where 0 = physiological amount, 1
= small amount, in the retropatellar space, 2 = moderate
amount, slight convexity of the suprapatellar bursa and
3 = large, capsular distension with bulging of the exten-
sor retinaculum [17,25].
Maximum global score was 12 for cartilage abnormal-
ities and 9 for BMLs, effusion and synovitis. Minimum
score was 0 for all assessed structural parameters.
The radiographs analysed using the Kellgren Lawrence
scoring method (K/L), as this is a recommended and
reliable method for baseline assessments of KOA using
the fixed flexion protocol with antero-posterior and lat-
eral radiographs [11]. One experienced investigator
(MB), who was blinded to randomization, analyzed all
radiographs and MRI scans in a random order.
Interventions
Subjects were randomly assigned to either a control
group or an intervention group who was treated with a
dietary regime. This consisted of a low-energy diet (LED)
for eight weeks followed by 24 weeks of conventional
hypo-energetic and high protein diet. As previously
described [5] the intervention-diet consisted of nutrition
powder (Speasy, Dansk Droge A/S) dissolved in water
and it was taken as six daily meals, giving the patient 3.4
MJ/day. This fulfilled the recommendations of daily
intake of high quality protein [26]; 37 energy percent (E
%) from soy protein providing the essential amino acids,
47 E% from carbohydrate, 16 E% from vegetable fat (pri-
marily from rapeseed oil), and fibres from oat-bran (15 g/
day). The LED group received nutritional instruction and
behavioural therapy by an experienced dietician at weekly
sessions (1.5 h/week) throughout the eight weeks. This
was done to reinforce and continuously stimulate the
patients’ intention to loose weight, and to promote a high
degree of compliance.
Patients in the control group attended a thorough
two-hour session at baseline (by the same dietician who
treated the LED group). The patients were given nutri-
tional advice and recommended ordinary foods in
amounts that would provide the patients with approxi-
mately 5 MJ/day. After this initial session all the patients
in the control group received ideas for a diet plan in a
booklet providing the participants with a variety of
‘good-advices’ when trying to reduce body weight.
Finally the subjects in the control group were put on a
waiting list for later recall to a similar dietary plan as in
the intervention group. The follow-up visit was at t = 32
weeks.
Biometric examinations
At baseline and after half a year (t = 32 weeks) the body
weights (without coats, shoes etc.) of all patients’ were
recorded on a decimal scale (TANITA BW-800, ‘Freder-
iksberg Vægtfabrik’, Copenhagen, Denmark).
Symptom assessment
The patient important outcome being their experience
of KOA symptoms were assessed by the Western
Ontario and McMaster Universities’ (WOMAC) OA
index, a validated disease-specific questionnaire com-
prised of three self-reported items; five pain-related
questions of each 100 mm VAS (500 mm VAS in total);
seventeen disability-related questions of each 100 mm
VAS (1700 mm VAS in total); two stiffness-related ques-
tions of each 100 mm VAS (200 mm VAS in total). The
patients mark their present level of symptoms, within
each of the above described items, by placing a vertical
line on a 100 mm horizontal line. The total WOMAC is
a measure of the global KOA level of symptoms; 0 mm
WOMAC representing no disease, and 2400 mm
WOMAC representing worst possible state of disease
[27]. This was done at baseline and again at follow-up (t
= 32 weeks).
Randomization, allocation concealment, implementation
and blinding
A method of restricted randomization called minimiza-
tion was used with stratifying patients according to (i)
gender, (ii) BMI and (iii) age. This was done for every
sixteen patients included, and ensured homogeneity
between the groups [28].
Each randomization list was drawn up by the statisti-
cian and given to the secretariat. In order to implement
the random allocation, the sequence was concealed until
interventions were assigned: The secretariat informed
the patients about when to meet with the dietician (i.e.
only implicitly referring to group allocation). The code
was not revealed to the researchers before data collec-
tion, imaging assessments and laboratory analyses were
complete.
The statistician and the assessor of radiographs and
MRI scans were blinded.
Statistical methods
Clinical outcomes were analyzed as differences from
baseline values (x32 - x0), and weight loss (kg) was also
analyzed as a relative measure, being the percentage
change from baseline ((x32 - x0)/x0 *100%). We per-
formed a distribution-free Spearman’s test of rank
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correlation when examining the possible relationship
between imaging variables and clinical outcomes of the
dietary interventions. Further analyses on significant
results were carried out according to the data type. The
Spearman correlation coefficient was interpreted as fol-
lows: < 0.3: none; 0.31-0.5: weak; 0.51-0.7: strong; 0.71-
0.9: very strong and > 0.9: excellent. A P-value less than
0.05 (two-tailed) or a 95% confidence interval (CI) not
including the null hypothesis was regarded as statisti-
cally significant. All the analyses were performed on
SAS version 9.1 for Windows (Chicago, IL, USA).
Results
Population characteristics
32 patients were invited to participate, 31 of these were
interested and 30 patients had baseline measurements
performed. The patient not randomized was excluded
due to withdrawal of consent before the randomization
procedure. The 30 enrolled patients were randomly
assigned to either LED or conventional hypo energetic
diet. Following randomization of 15 patients to each
group, all patients completed the trial and we subse-
quently analyzed the ITT population based on these 30
patients (Figure 1).
All patients were women, average age was 62 years
(SD 6.8) and average BMI was 37 kg/m 2 (SD 6.0) (see
table 1). At baseline we registered data regarding blood
analyses and Patient-Reported Outcomes (PROs); there
were no statistically significant differences between
patients in the LED and control group at baseline (data
not shown). Use of pain medication was also monitored
by PROs and data revealed an unaltered use during the
trial period.
Radiographs were scored using the K/L score, and the
three joint compartments were scores separately in
order to assess whether KOA at specific locations had
any influence on our hypothesis. No group differences
(data not shown). 63% of the patients had a medial K/L
score ≥ 2 and 13% had a K/L score of 0 (no group dif-
ferences). The assessment of MRI scans revealed that
37% of the patients had a BML score ≥ 1 for all three
compartments and that 93% of the patients had some
degree of cartilage abnormalities (score ≥ 1). For effu-
sion and synovitis 30 and 40% had a score of zero
respectively.
Assessed imaging variables as predictors of symptomatic
changes following weight loss
Imaging variables as predictors of symptomatic outcome
were examined by a Spearman correlation analysis
(Table 2). The analysis did not show significant correla-
tion between any imaging variables and the following
outcomes; Δ WOMAC pain (mm) and Δ WOMAC dis-
ability (mm) (r ≤ 0.33; p > 0.05).
Results regarding the weight loss program
Results from the intention-to-treat population are dis-
played in Table 3. The LED and control group changed
their mean body weight (SE) by -15.6 (3.6)% and 0.4
(3.2)% respectively (data not shown).
In terms of responders, 40% vs. 13% of the patients in
the LED and control group, respectively, achieved a pain
reduction of more than 50% in the WOMAC-pain index
and 33% vs. 7% of the patients in the LED and control
group achieved > 50% in the WOMAC total index.. The
WOMAC disability index showed improvement in the
LED group when compared with the control group, MD
of - 266 mm (95%CI: -468.9 to -63.1; p < 0.01) (data not
shown).
Adverse events
No significant adverse events were reported.
Discussion
We found that KOA related structural changes seen on
radiographs and MRI scans, at baseline, did not rule out
improvement of symptoms following a clinically signifi-
cant weight loss and could not predict the symptomatic
outcome of the diet intervention in this elderly sample
of female obese KOA patients. This result was found in
an intervention group in which 90% of the patients
experienced a significant weight reduction (> 10%), and
33% of the patients experienced > 50% reduction in
their overall symptoms of KOA. The results correspond
to prior studies investigating short-term effects of
weight-loss and long-term outcome of total knee joint
replacement [5,29]. We believe that these findings could
be valuable for the future design of trials examining the
benefit of weight loss in KOA patients, as it indicates
that none of the examined structural parameters, indivi-
dually or combined, could predict the symptomatic out-
come of a significant weight loss in obese women with
KOA.
A prior study investigating synovitis at baseline and
clinical symptoms after two months, found no associa-
tion [30], while Hill et al found a change in synovitis to
be associated with change in symptoms of pain [18].
Furthermore, several cross-sectional studies have investi-
gated MRI assessed items in relation to e.g. clinical
symptoms, and in a meta-analysis BMLs and effusion/
synovitis were found to be associated with knee pain
[31].
The study has several limitations. It includes only 30
patients, secondly, the use of radiographs and low-field
MRI are not the most advanced diagnostic tools regard-
ing imaging assessment of osteoarthritis. Also, a follow-
up period of 32 weeks might influence our findings.
The main disadvantage of low field MRI is the poorer
image quality due to low SNR, which can only be
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compensated for by increasing either number of excita-
tions, slice thickness and/or Field of Window or by
reducing matrix and/or receiver bandwidth. All of which
will increase scan time and/or decrease the in-plane
resolution. Smaller cartilage abnormalities is not as well
detected by low field MRI when compared to medium
or high field MRI [32], but unfortunately a recent review
that could have brought new insight to the subject,
could not complete a meta-analysis due to study hetero-
geneity [33]. We applied a near isotropic sub millimetre
3 D GRE sequence and assessed images in several planes
in order to achieve the highest possible diagnostic accu-
racy [34,35].
Finally we did not include analysis of multiple differ-
ent scoring methods for radiographs and MRI scans, but
the current approach was chosen inspired by several
Assessed for eligibility (n= 31)
Excluded (n= 1)
Withdrawal of consent (n=1)
Randomized (n= 30)
En
ro
llm
en
t
A
llo
ca
tio
n
Drop out (n= 0)
Allocated to control-group 
(n= 15)
Fo
llo
w
-
u
p:
 h
al
f a
 y
ea
r
A
n
a
ly
sis
Drop out (n=0 )
Analyzed (n=15)Analyzed (n=15)
Allocated to intervention-
group (n= 15)
Figure 1 Trial profile.
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previous publications investigating this topic
[17,22-25,36]. Newest evidence supports this approach
as BMLs, synovitis and effusion seems to be the most
important MRI assessed items likely to be associated
with knee pain in KOA [31].
Conclusion
In conclusion the present study reveals that baseline
joint status assessed by low field MRI scans (0.2 T) and
bi-plane standing radiographs did not influence the
long-term improvement in WOMAC disability and
WOMAC total indexes following a clinically relevant
weight loss. The present study also demonstrated that
an initial diet intervention program was able to induce a
sustainable weight loss in KOA patients over a period of
half a year (32 weeks).
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Table 1 Characteristics of all participants
Mean (SD) (range)
Total (n = 30)
Age (years) 62.4 (6.8) (51.2-79.6)
Height (m) 1.6 (0.06) (1.52-1.76)
Weight (kg) 99.4 (14.5) (79.1-144.8)
BMI (kg/m2) 36.8 (6.0) (29.4-57.3)
Sedimentation rate 2 16.0 (12.0; 23.0) (5.0-48.0)
C-reactive protein 2 5.0 (2.6; 7.5) (1.0-12.6)
Pain (mm) 197.6 (96.0) (26.0-344.0)
Disability (mm) 660.2 (345.6) (58.0-1365.0)
Stiffness (mm) 88.8 (46.5) (0.0-170.0)
Total index (mm) 944.7 (438.2) (205.0-1866.0)
Median (range)
Total (n = 30)
Kellgren Lawrence Score
Medial 2 (0-4)
Lateral 1 (0-3)
Patellofemoral 2 (0-4)
Total 5 (0-9)
MRI score
BML 2 (0-2)
Cartilage 4 (0-7)
Effusion 3 (0-9)
Synovitis 3 (0-6)
Total score 9 (0-20)
1 Sum of visual analogue scale scores; WOMAC-pain-index of 500 mm,
-disability-index of 1700 mm, -stiffness-index of 200 mm and -total-index of
2400 mm (se text in article under Symptom assessment).
2 Showed a Non-Gaussian distribution, thus presented as median (interquartile
range).
Table 2 Correlation of baseline imaging variables with change in symptoms
All patients (n = 30) The weight loss arm (n = 15)
Δ Pain (%) 1 Δ Disability (%) 1 Δ Pain (%) 1 Δ Disability (%) 1
K/L score
Medial chamber r = 0.03; (P = 0.86) r = 0.16; (P = 0.39) r = -0.15; (P = 0.59) r = -0.09; (P = 0.75)
Lateral chamber r = 0.10; (P = 0.59) r = -0.03; (P = 0.89) r = 0.14; (P = 0.61) r = 0.20; (P = 0.48)
Patellofemoral chamber r = 0.03; (P = 0.87) r = -0.09; (P = 0.61) r = -0.17; (P = 0.55) r = -0.19; (P = 0.50)
Total score r = 0.13; (P = 0.50) r = -0.003; (P = 0.98) r = -0.08; (P = 0.79) r = -0.07; (P = 0.79)
MRI score
BML r = 0.03; (P = 0.86) r = -0.05; (P = 0.80) r = 0.29; (P = 0.29) r = 0.03; (P = 0.91)
Cartilage r = 0.10; (P = 0.58) r = -0.09; (P = 0.65) r = 0.04; (P = 0.90) r = -0.43; (P = 0.11)
Effusion r = 0.15; (P = 0.44) r = 0.04; (P = 0.82) r = -0.11; (P = 0.71) r = 0.07; (P = 0.79)
Synovitis r = 0.17; (P = 0.36) r = 0.11; (P = 0.55) r = -0.004; (P = 0.99) r = -0.15; (P = 0.60)
Total r = 0.19; (P = 0.31) r = 0.03; (P = 0.88) r = -0.02; (P = 0.94) r = -0.18; (P = 0.52)
1 Measured by the WOMAC-index.
Table 3 Results based on changes for the whole
intention-to-treat population
Characteristics Mean (SD)
Total (n = 30)
Δ Weight (kg) -7.8 (9.1)
Δ BMI (kg/m2) -2.9 (3.4)
WOMAC index 1
Δ Pain (mm) -39 (94)
Δ Disability (mm) -105 (299)
Δ Stiffness (m,) -21 (42)
Δ Total index (mm) -163 (374)
1 Sum of visual analogue scale scores.
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